Compass Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | DEFA14A: Others
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
Compass Therapeutics | DEFA14A: Others
Compass Therapeutics | DEF 14A: Definitive information statements
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Compass Therapeutics | 8-K: Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
Compass Therapeutics | DEFA14A: Others
Compass Therapeutics | DEF 14A: Definitive proxy statements
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 8-K: Current report
No Data
No Data